Skip to main content
Clinical Trials/JPRN-UMIN000031292
JPRN-UMIN000031292CompletedPhase 2

The clinical study to elucidate the effects of Oligonol and the prescription containing Oligonol on the blood flow and its relative body functions. - Clinical trial for improvement of blood flow and its relative body functions.

Faculty of Health Care, Teikyo Heisei University0 sites25 target enrollmentStarted: May 1, 2019Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
25

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
16years-old to 70years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) person who ingests drug or supplement to improve the blood flow. 2) person who has chronic diseases and ingests the drugs. 3) heavy smoker (over 21/day) 4) heavy drunker (over 20 g of ethanol/day) 5) person who has the potential of allergy against drugs and foods especially, lychee and green tea. 6) person who are pregnant or expected to be pregnant, or lactating during the study. 7) person who cannot stop excess ingesting of the food containing large amount polyphenol such as green tea or brown tea. 8) person who is judged as ineligible by doctor.

Investigators

Sponsor
Faculty of Health Care, Teikyo Heisei University

Similar Trials